Dellinger RW - Search Results

1

Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD⁺ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.

Dellinger RW, Santos SR, Morris M, Evans M, Alminana D, Guarente L, Marcotulli E. Dellinger RW, et al. NPJ Aging Mech Dis. 2018 Aug 20;4:8. doi: 10.1038/s41514-018-0027-1. eCollection 2018. NPJ Aging Mech Dis. 2018. PMID: 30155270 Free PMC article.

2

Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD⁺ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.

Dellinger RW, Santos SR, Morris M, Evans M, Alminana D, Guarente L, Marcotulli E. Dellinger RW, et al. NPJ Aging Mech Dis. 2017 Nov 24;3:17. doi: 10.1038/s41514-017-0016-9. eCollection 2017. NPJ Aging Mech Dis. 2017. PMID: 29184669 Free PMC article.

3

Nicotinamide riboside with pterostilbene (NRPT) increases NAD⁺ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI.

Simic P, Vela Parada XF, Parikh SM, Dellinger R, Guarente LP, Rhee EP. Simic P, et al. BMC Nephrol. 2020 Aug 13;21(1):342. doi: 10.1186/s12882-020-02006-1. BMC Nephrol. 2020. PMID: 32791973 Free PMC article. Clinical Trial.

4

Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm.

Marinescu AG, Chen J, Holmes HE, Guarente L, Mendes O, Morris M, Dellinger RW. Marinescu AG, et al. Among authors: dellinger rw. Int J Toxicol. 2020 Jul/Aug;39(4):307-320. doi: 10.1177/1091581820927406. Int J Toxicol. 2020. PMID: 32715855

5

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trial.

Dellinger RW, Holmes HE, Hu-Seliger T, Butt RW, Harrison SA, Mozaffarian D, Chen O, Guarente L. Dellinger RW, et al. Hepatology. 2023 Sep 1;78(3):863-877. doi: 10.1002/hep.32778. Epub 2022 Nov 22. Hepatology. 2023. PMID: 36082508 Clinical Trial.

6

Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.

de la Rubia JE, Drehmer E, Platero JL, Benlloch M, Caplliure-Llopis J, Villaron-Casales C, de Bernardo N, AlarcÓn J, Fuente C, Carrera S, Sancho D, GarcÍa-Pardo P, Pascual R, JuÁrez M, Cuerda-Ballester M, Forner A, Sancho-Castillo S, Barrios C, Obrador E, Marchio P, Salvador R, Holmes HE, Dellinger RW, Guarente L, Estrela JM. de la Rubia JE, et al. Among authors: dellinger rw. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):115-122. doi: 10.1080/21678421.2018.1536152. Epub 2019 Jan 22. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 30668199 Clinical Trial.

7

Pterostilbene in Cancer Therapy.

Obrador E, Salvador-Palmer R, Jihad-Jebbar A, López-Blanch R, Dellinger TH, Dellinger RW, Estrela JM. Obrador E, et al. Among authors: dellinger rw. Antioxidants (Basel). 2021 Mar 21;10(3):492. doi: 10.3390/antiox10030492. Antioxidants (Basel). 2021. PMID: 33801098 Free PMC article. Review.

8

NAD⁺ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis.

Obrador E, Salvador-Palmer R, López-Blanch R, Dellinger RW, Estrela JM. Obrador E, et al. Among authors: dellinger rw. Biomedicines. 2021 Aug 12;9(8):1000. doi: 10.3390/biomedicines9081000. Biomedicines. 2021. PMID: 34440204 Free PMC article. Review.

9

Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD⁺ without impacting respiratory capacity or insulin sensitivity.

Damgaard MV, Nielsen TS, Basse AL, Chubanava S, Trost K, Moritz T, Dellinger RW, Larsen S, Treebak JT. Damgaard MV, et al. Among authors: dellinger rw. iScience. 2022 Feb 2;25(2):103863. doi: 10.1016/j.isci.2022.103863. eCollection 2022 Feb 18. iScience. 2022. PMID: 35198907 Free PMC article.

10

Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301.

Fels JA, Casalena G, Konrad C, Holmes HE, Dellinger RW, Manfredi G. Fels JA, et al. Among authors: dellinger rw. Hum Mol Genet. 2022 Oct 10;31(20):3458-3477. doi: 10.1093/hmg/ddac118. Hum Mol Genet. 2022. PMID: 35652455 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page